MD Anderson Cancer Center

Clinical research site in Huston, Texas

As of July 2026, 1 paid clinical trial is recruiting at MD Anderson Cancer Center in Huston, Texas. Active studies at this site cover conditions such as Chronic Myelomonocytic Leukemia, Leukemia, Myeloid, Acute and Myelodysplastic Syndrome With Excess Blasts-2. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at MD Anderson Cancer Center (1)

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

for Leukemia, Myeloid, Acute

10 locations incl. Birmingham

Sponsor: Aptose Biosciences Inc.

Sex: All·Age: 18+

Code: NCT03850574·Phase 1, Phase 2·Recruiting·Listed Feb 2019

Apply to this trial

Explore more

Paid clinical trials in Huston, TX · Texas clinical trials